Business
Avidity Biosciences Engages with Patient Communities During National Muscular Dystrophy Awareness Month as part of Commitment to Developing Muscular Dystrophy Programs
Company remains on track to have three muscular dystrophy programs in clinic by end of year SAN DIEGO, Sept. 7, 2022 /PRNewswire/ -- Avidity Biosciences, Inc.
About this update from Atrium Therapeutics, Inc.
[{"type":"text","content":"Company remains on track to have three muscular dystrophy programs in clinic by end of year \nSAN DIEGO, Sept. 7, 2022 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), honors National Muscular Dystrophy Awareness Month, an annual observance that raises awareness for families across the nation who are living with neuromuscular diseases. This month Avidity will also raise awareness and support patient-focused activities for World Duchenne Awareness Day on September 7 and International Myotonic Dystrophy Awareness Day on September 15. Avidity is on track to have three rare muscular dystrophy programs in the clinic by the end of this year for myotonic dystrophy type 1 (DM1), Facioscapulohumeral muscular dystrophy (FSHD) and Duchenne muscular dystrophy (DMD).\n\n \n \n \n \n \n \n\n \n\"We look forward to engaging with patient communities and their families this month to better understand their unique journeys and experiences. We are excited to welcome many of our partners here to San Diego where we will be participating at the MDF Annual Conference, FSHD Society's Walk and Roll to Cure FSHD, and the Global Genes RARE Patient Advocacy Summit,\" said Sarah Boyce, president and chief executive officer. \"At Avidity, we are committed to listening, learning and partnering with the patient and advocacy community as part of our mission to improve the lives of people affected by serious rare diseases. We are on track to have three rare muscular dystrophy programs in the clinic by the end of this year.\"\nIn support of Muscular Dystrophy Awareness Month, Avidity will be engaging in various activities with patient and advocacy communities including:\nWelcoming patients and families to tour Avidity's office during the 2022 Myotonic Dystrophy Foundation (MDF) Annual Conference, an event to unite community, care and a cure for myotonic dystrophySupporting Jett Foundation's Stronger than Duchenne World Duchenne Awareness eventRecognizing International Myotonic Dystrophy Awareness Day as a proud member of the Global Alliance for Myotonic Dystrophy AwarenessJoining in the FSHD Society's 2022 Walk & Roll to Cure FSHD in San Diego, the only international event focused solely on funding progress for FSHD Parti...